Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accounts Payables (2016 - 2025)

iBio (IBIO) has disclosed Accounts Payables for 15 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 332.25% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 332.25% year-over-year, with the annual reading at $2.2 million for FY2025, 511.17% up from the prior year.
  • Accounts Payables for Q4 2025 was $2.7 million at iBio, down from $2.8 million in the prior quarter.
  • The five-year high for Accounts Payables was $5.3 million in Q1 2022, with the low at $358000.0 in Q2 2024.
  • Average Accounts Payables over 5 years is $2.4 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Accounts Payables crashed 80.64% in 2024, then surged 511.17% in 2025.
  • Over 5 years, Accounts Payables stood at $2.7 million in 2021, then soared by 46.11% to $4.0 million in 2022, then crashed by 53.55% to $1.9 million in 2023, then crashed by 66.97% to $614000.0 in 2024, then soared by 332.25% to $2.7 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $2.7 million, $2.8 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.